295 related articles for article (PubMed ID: 30868361)
1. Metabolomics profiles of patients with Wilson disease reveal a distinct metabolic signature.
Sarode GV; Kim K; Kieffer DA; Shibata NM; Litwin T; Czlonkowska A; Medici V
Metabolomics; 2019 Mar; 15(3):43. PubMed ID: 30868361
[TBL] [Abstract][Full Text] [Related]
2. Dysregulated Choline, Methionine, and Aromatic Amino Acid Metabolism in Patients with Wilson Disease: Exploratory Metabolomic Profiling and Implications for Hepatic and Neurologic Phenotypes.
Mazi TA; Sarode GV; Czlonkowska A; Litwin T; Kim K; Shibata NM; Medici V
Int J Mol Sci; 2019 Nov; 20(23):. PubMed ID: 31779102
[TBL] [Abstract][Full Text] [Related]
3. Metabolomic and biochemical changes in the plasma and liver of toxic milk mice model of Wilson disease.
Liu Q; Wu X; Liu C; Wang N; Yin F; Wu H; Cao S; Zhao W; Wu H; Zhou A
J Pharm Biomed Anal; 2024 Aug; 246():116255. PubMed ID: 38795427
[TBL] [Abstract][Full Text] [Related]
4. Metabolomic profiling of Wilson disease, an inherited disorder of copper metabolism, and diseases with similar symptoms but normal copper metabolism.
Qiu Y; Su M; Xiao X; Zhou D; Xie L
Orphanet J Rare Dis; 2023 Sep; 18(1):282. PubMed ID: 37697371
[TBL] [Abstract][Full Text] [Related]
5. Epigenomic signatures in liver and blood of Wilson disease patients include hypermethylation of liver-specific enhancers.
Mordaunt CE; Kieffer DA; Shibata NM; Członkowska A; Litwin T; Weiss KH; Zhu Y; Bowlus CL; Sarkar S; Cooper S; Wan YY; Ali MR; LaSalle JM; Medici V
Epigenetics Chromatin; 2019 Feb; 12(1):10. PubMed ID: 30709419
[TBL] [Abstract][Full Text] [Related]
6. Metabolic profiling of copper-laden hepatolenticular degeneration model rats and the interventional effects of Gandou decoction using UPLC-Q-TOF/MS.
Cheng M; Wu H; Wu H; Liu X; Zhou A
J Pharm Biomed Anal; 2019 Feb; 164():187-195. PubMed ID: 30390561
[TBL] [Abstract][Full Text] [Related]
7. Exploration of TCM syndrome types of the material basis and risk prediction of Wilson disease liver fibrosis based on
Chen H; Wang X; Zhang J; Xie D; Pu Y
J Pharm Biomed Anal; 2024 Aug; 245():116167. PubMed ID: 38663257
[TBL] [Abstract][Full Text] [Related]
8. Hepatic features of Wilson disease.
Boga S; Ala A; Schilsky ML
Handb Clin Neurol; 2017; 142():91-99. PubMed ID: 28433114
[TBL] [Abstract][Full Text] [Related]
9. Study of the metabolomics characteristics of patients with metabolic syndrome based on liquid chromatography quadrupole time-of-flight mass spectrometry.
Wu N; Wang W; Yi M; Cheng S; Wang D
Ann Endocrinol (Paris); 2018 Feb; 79(1):37-44. PubMed ID: 29246383
[TBL] [Abstract][Full Text] [Related]
10. Diagnosis of Wilson Disease and Its Phenotypes by Using Artificial Intelligence.
Medici V; Czlonkowska A; Litwin T; Giulivi C
Biomolecules; 2021 Aug; 11(8):. PubMed ID: 34439909
[TBL] [Abstract][Full Text] [Related]
11. Application of LC-MS-based metabolomics method in differentiating septic survivors from non-survivors.
Liu Z; Yin P; Amathieu R; Savarin P; Xu G
Anal Bioanal Chem; 2016 Nov; 408(27):7641-7649. PubMed ID: 27614981
[TBL] [Abstract][Full Text] [Related]
12. Liver and urine metabolomics reveal the protective effect of Gandou decoction in copper-laden Hepatolenticular degeneration model rats.
Xu R; Liang J; Cheng M; Wu H; Wu H; Cao S; Zhao W; Xu R; Zhou A
J Chromatogr B Analyt Technol Biomed Life Sci; 2021 Aug; 1179():122844. PubMed ID: 34246170
[TBL] [Abstract][Full Text] [Related]
13. Metabolomic Analysis Using Liquid Chromatography/Mass Spectrometry for Gastric Cancer.
Liang Q; Wang C; Li B
Appl Biochem Biotechnol; 2015 Aug; 176(8):2170-84. PubMed ID: 26088916
[TBL] [Abstract][Full Text] [Related]
14. Severe dysfunction of respiratory chain and cholesterol metabolism in Atp7b(-/-) mice as a model for Wilson disease.
Sauer SW; Merle U; Opp S; Haas D; Hoffmann GF; Stremmel W; Okun JG
Biochim Biophys Acta; 2011 Dec; 1812(12):1607-15. PubMed ID: 21920437
[TBL] [Abstract][Full Text] [Related]
15. Metabolomics of papillary thyroid carcinoma tissues: potential biomarkers for diagnosis and promising targets for therapy.
Shang X; Zhong X; Tian X
Tumour Biol; 2016 Aug; 37(8):11163-75. PubMed ID: 26935059
[TBL] [Abstract][Full Text] [Related]
16. Liquid chromatography-mass spectrometry-based urinary metabolomics study on a rat model of simulated microgravity-induced depression.
Xu T; Lu C; Feng L; Fan LX; Sun J; Fan B; Wang Q; Wang Y; Liu XM; Wang FZ
J Pharm Biomed Anal; 2019 Feb; 165():31-40. PubMed ID: 30502550
[TBL] [Abstract][Full Text] [Related]
17. Effects of tetrathiomolybdate on copper metabolism in healthy volunteers and in patients with Wilson disease.
Kirk FT; Munk DE; Swenson ES; Quicquaro AM; Vendelbo MH; Larsen A; Schilsky ML; Ott P; Sandahl TD
J Hepatol; 2024 Apr; 80(4):586-595. PubMed ID: 38081365
[TBL] [Abstract][Full Text] [Related]
18. 1H NMR-based metabolomics investigation of copper-laden rat: a model of Wilson's disease.
Xu J; Jiang H; Li J; Cheng KK; Dong J; Chen Z
PLoS One; 2015; 10(4):e0119654. PubMed ID: 25849323
[TBL] [Abstract][Full Text] [Related]
19. [Wilson disease: an update].
Seo JK
Korean J Hepatol; 2006 Sep; 12(3):333-63. PubMed ID: 16998287
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
